WHAT: Cenduit, a joint venture between Quintiles and Thermo Fisher Scientific, is showcasing its solutions and expertise as the largest interactive response technology (IRT) specialist in the world at the 2016 Global Clinical Supplies Group Annual Conference from April 24-27 in Tampa, Florida. “The Global Clinical Supplies Group Annual Conference is a great platform to discuss current trial and supply challenges with conference attendees,” said Brice Freer, account executive at Cenduit. “Cenduit’s booth will be a great resource for visitors to learn more about our innovative IRT systems, in addition to our commitment to delivering customized solutions designed to help customers save money and enhance drug and patient management for clinical trials.” Attendees are invited to stop by the Cenduit booth, #3, to learn how the company’s IRT solutions can help sponsors increase efficiencies and reduce costs to get their product to market faster. WHO: Cenduit representatives at the conference: • Brice Freer, account executive • Rick Lavalle, new business executive WHEN: April 24-27, 2016
WHERE: Grand Hyatt Tampa Bay
2900 Bayport Drive
Tampa FL 33607
DETAILS: For media inquiries, please contact Greyson Feurer at Largemouth Communications, (919) 459-6460, greyson@largemouthpr.com.
ABOUT: Cenduit, a joint venture between Quintiles and Thermo Fisher Scientific, is the largest IRT specialist in the world with the expertise to empower sponsors for success by implementing a completely personalized system that puts them in control of their clinical trials. With the needs of investigator sites and patients top of mind, Cenduit offers clinical supply chain intelligence and clinical operations know-how through its IRT-driven services: patient randomization, patient reminders, drug supply management, and eClinical integration. Cenduit has offices in the US, UK, Switzerland, India, and Japan, and global clinical trial experience in more than 100 countries, interacting with more than 600,000 patients at more than 32,000 sites. For additional information, visit Cenduit online at www.cenduit.com; on Twitter @CenduitLLC or on LinkedIn at www.LinkedIn.com/Company/Cenduit.
